{"id":18619,"date":"2021-10-19T14:06:03","date_gmt":"2021-10-19T14:06:03","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=80803"},"modified":"2021-10-19T14:06:03","modified_gmt":"2021-10-19T14:06:03","slug":"woven-sciences-el-puente-releases-its-policy-paper-on-indigenous-reciprocity-corporate-social-responsibility","status":"publish","type":"post","link":"https:\/\/myanmarnewswire.com\/woven-sciences-el-puente-releases-its-policy-paper-on-indigenous-reciprocity-corporate-social-responsibility\/","title":{"rendered":"Woven Science\u2019s El Puente Releases Its Policy Paper on Indigenous Reciprocity & Corporate Social Responsibility"},"content":{"rendered":"

Woven Science’s El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public policymakers in collaboration with companies can offer indigenous communities influence over product development, consumer preferences, profit sharing, and public perception.<\/h4>\n

NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) — Woven Science’s El Puente\u00a0foundation is pleased to release for public comment its\u00a0policy paper and corporate social responsibility initiative<\/u><\/a>\u00a0for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public policymakers in collaboration with companies can offer indigenous communities influence over product development, consumer preferences, profit sharing, and public perception.<\/p>\n

The public comment period will last the next 45 days. You can comment on the paper by filling in the intake form\u00a0linked here<\/u><\/a>\u00a0or by emailing us directly at elpuente@woven.science. We will respond to your comments and integrate them into the final paper.<\/p>\n

After interviewing leaders throughout both the psychedelics and pharmaceutical industries, we’ve identified four public policy solutions to explore:<\/p>\n